Raza Bokhari - 31 Dec 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MDCX
Reported as of: 31 Dec 2024
Net transaction value: $0
SEC form: 3/A - Amendment
Accepted by SEC: 10 Feb 2025, 16:55:32 UTC
Original report date: 31 Dec 2024
Next SEC filing: 24 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Raza Bokhari

Key filing fact

Raza Bokhari filed Form 3/A - Amendment for Medicus Pharma Ltd. (MDCX) on 10 Feb 2025.

Key facts

This page summarizes Raza Bokhari's Form 3/A - Amendment filing for Medicus Pharma Ltd. (MDCX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 10 Feb 2025, 16:55.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX holding

Common Shares, no par value ("Common Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 793,173
Date: 31 Dec 2024
Ownership: See Footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This amendment is being filed to correct the number of Common Shares reported to be indirectly held by the Reporting Person.

Footnote F2

Held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.